Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 [1] until 2022, when he resigned in order to join the cellular reprogramming venture Altos Labs in August of that year. [2][3][4] Prior to this he served as president of research ...
Rino Rappuoli ForMemRS (born 4 August 1952) is an Italian immunologist. He is the head of vaccine research and development (R&D) at GlaxoSmithKline (GSK) Vaccines. [1] Previously, he has served as visiting scientist at Rockefeller University and Harvard Medical School and held roles at Sclavo, Vaccine Research and CSO, Chiron Corporation, and ...
GSK has so far focused on producing its adjuvant technology to boost the immune response of others' vaccines, and has teamed up with companies such as Vir and CureVac to develop treatments and ...
Alma mater. Stanford University. New York University. Occupations. Physician. gastroenterologist. pharmaceutical executive. Tadataka " Tachi " Yamada KBE (山田忠孝 Yamada Tadataka or "ターチ Tachi"; 5 June 1945 – 4 August 2021) was a Japanese-born American physician and gastroenterologist. He was a venture partner of Frazier Healthcare ...
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Joseph W. Tobin. Joseph William Tobin, CSsR, (born May 3, 1952) is an American prelate of the Catholic Church. A member of the Redemptorist order, he has been the Archbishop of Newark since 2017. He previously served as the Archbishop of Indianapolis from 2012 to 2016 and as secretary of the Congregation for Institutes of Consecrated Life and ...
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.